The largest database of trusted experimental protocols

72 protocols using anti cd11b microbead

1

Immune Cell Isolation from Wounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wounds were digested as described above. Single cell suspensions were incubated with fluorescein isothiocyanate–labeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by anti–fluorescein isothiocyanate microbeads (Miltenyi Biotec). Flow-through was then incubated with anti-CD11b microbeads (Miltenyi Biotec) to isolate the non-neutrophil, non-lymphocyte, CD11b+ cells. Cells were saved in Trizol (Invitrogen) for quantitative RT-PCR analyses.
+ Open protocol
+ Expand
2

Isolation and Analysis of Brain Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type animals were infected with 1.3 × 105 CFU SC5314 and euthanized at 24 h post-infection. Brains were digested as above and leukocytes stained with sterile antibodies55 . Ly6Chi monocytes (CD45hi CD11b+ Ly6Chi Ly6G) and microglia (CD45lo CD11b+ Ly6G Ly6C) were FACS-sorted into sterile sorting buffer (HBSS supplemented with 2 mM EDTA, 10 % FCS, 100 U/mL penicillin, 100 μg/mL streptomycin) using a FACS Aria instrument for downstream qRT-PCR and immunoblot analyses. Purity of cells were greater than >95%, on average. In some experiments (qRT-PCR of CLRs in brain-resident microglia; Supplementary Fig. 1), microglia were instead sorted by magnetic separation using anti-CD11b microbeads (Miltenyi). Cells were then centrifuged (1500 rpm 5 min, 4 °C) and resuspended in Trizol for RNA purification or RIPA buffer for downstream immunoblot analysis. Depending on the experiment, up to 5 animals were pooled for individual sorts, or individual mice were analyzed separately (see Figure legends for details).
+ Open protocol
+ Expand
3

Purification of Murine CD11b+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For adoptive transfer experiments, magnetic-activated cell sorting (MACS) was used to further isolate CD11b+ cells from donor animals to assure purity and simplify FACS. C57BL/6J and mTmG spleens were isolated from donor animals, immersed in RPMI, crushed and filtered through a 100-μm filter, passed through a Ficoll gradient, washed, and resuspended in MACS buffer. Single cell suspensions were then incubated with fluorescein isothiocyanate-labeled anti-CD3, anti-CD19, and anti-Ly6G (Biolegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec; Cat. 130–042–401, 130–049–601). The suspension was then passed through a MACS column and flow-through was incubated with anti-CD11b microbeads (Miltenyi Biotec; Cat. 130–049–601). The flow-through was then passed through a separate column, flow-through eliminated, and then the column was purged to isolate non-neutrophil, non-T cell, non-B cell, and CD11b+ cells for expedited FACS.
+ Open protocol
+ Expand
4

ChIP-seq and RNA-seq of Transformed B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were prepared for ChIP-seq or ChIP-qPCR analysis according to Yamane et al. (2013) (link) with minor modifications. For each experiment, harvested cells were depleted of dead/apoptotic cells using the dead cell removal kit (Miltenyi Biotec) before further processing. For CEBPA experiments, myeloid cells were additionally enriched using anti-CD11B micro-beads (Miltenyi). Primary transformed and untransformed B cell precursors were typically harvested on day 7 after transduction; for CEBPA experiments, cells were harvested after 7 days of DOX addition. For library preparation, the NEBNext ChIP-Seq Library Prep Master Mix Set and NEBNext Multiplex Oligos for Illumina (NEB) were used. For RNA-seq, cells were isolated, cultured, and harvested as for ChIP-seq experiments. RNA was extracted in duplicate experiments from 5 × 106 cells using the QIAGEN RNeasy mini kit. Libraries were generated from pre-enriched mRNA using the NEBNext mRNA Library PrepReagent Set for Illumina (NEB) and pre-amplified using the NEBNext Multiplex Oligos for Illumina (NEB). A detailed description of the experimental procedures, bioinformatic analyses, and statistics is available in the Supplemental Experimental Procedures.
+ Open protocol
+ Expand
5

Crosstalk between CD4+ T cells and CD11b+ cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4 T cells from 2D2 mice and CD11b+ cells from EAE-recovered mice were sorted using anti-CD4 microbeads and anti-CD11b microbeads, respectively (Miltenyi Biotec). The resulting CD4+ T cell-enriched population (1 × 105 cells) was cocultured with the isolated CD11b+ cells (5 × 104 cells) without MOG-peptide addition in a 96 well plate for 3 days. IL-2 levels in cell culture supernatants were determined using ELISA kits (eBioscience).
+ Open protocol
+ Expand
6

Isolation and Purification of Tumor-associated Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subcutaneous, orthotopic or MMTV-PyMT tumours were excised, cut in small pieces, treated with 10 U ml−1 collagenase I, 400 U ml−1 collagenase IV and 30 U ml−1 DNaseI (Worthington) for 30 min at 37 °C, squashed and filtered. Red blood cells were removed using erythrocyte lysis buffer and density gradients (Axis-Shield) were used to remove debris and dead cells.
Tumour-draining LNs were cut, dissociated with 10 U ml−1 collagenase I, 400 U ml−1 collagenase IV and 30 U mL−1 DNaseI (Worthington) for 45 min at 37 °C and filtered.
Spleens were flushed with 200 U ml−1 collagenase III (Worthington) and left for 30 min at 37 °C. Afterwards, spleens were filtered and red blood cells were removed using erythrocyte lysis buffer.
To purify DC subpopulations from tumour, spleen or LNs, CD11c+ cells were MACS-enriched (anti-CD11c microbeads; Miltenyi) and sorted using BD FACSAria II (BD Biosciences) according to the gating strategy in Fig. 1a, Supplementary Fig. 6A or Supplementary Fig. 8A, respectively.
Bone marrow leukocytes were isolated through flushing of tibia and femur. The obtained cell suspensions were filtered, and red blood cells were removed using erythrocyte lysis buffer. To purify bone marrow monocytes, CD11b+ cells were MACS-enriched (anti-CD11b microbeads; Miltenyi) before sorting.
+ Open protocol
+ Expand
7

Immunofluorescence Staining of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for immunofluorescence: rat anti-CD68 (Acris), rabbit anti-CD86 (Abcam), rat anti-Ym1 (R&D Systems), rabbit anti-CD206 (Abcam), goat anti-macrophage galactose N-acetyl-galactosamine specific lectin (Mgl1/2, R&D Systems), rat anti-Ecadherin (Zymed), mouse anti-alpha-smooth muscle actin-Cy3 (α-SMA, Sigma-Aldrich), rabbit anti-Ki67 (Abcam). ProLong Gold with DAPI mounting media and Alexa-conjugated secondary antibodies were purchased from Invitrogen. DRAQ5 (1,5-bis{[2-(di-methylamino) ethyl]amino}-4, 8-dihydroxyanthracene-9,10-dione) was purchased from Biostatus Limited. Anti-CD11b microbeads and magnetic separation equipment were obtained from Miltenyi Biotec. Gel-purified Escherichia coli LPS (O55:B5), deoxyribonuclease I from bovine pancreas Type IV (DNase), and collagenase from clostridium histolyticum, Type XI were obtained from Sigma-Aldrich. Recombinant mouse IL-4 and IL-13 were purchased from R&D Systems. RPMI 1640 media was purchased from Invitrogen, and FBS was purchased from Thermo Fisher Scientific.
+ Open protocol
+ Expand
8

Purification of MDSCs and DO11.10 T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To purify MDSCs, splenocytes from tumor‐bearing mice were stained with anti‐CD11b microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and enriched by positive selection using the MACS technique (Miltenyi Biotec). To obtain DO11.10 T cells, CD4+ T cells were isolated via negative selection using a CD4+ T‐cell isolation kit (Miltenyi Biotec).
For the isolation of tumor infiltrating leukocytes (TILs), solid tumors were isolated from CT26 tumor‐bearing mice. The tumors were fragmented and digested with collagenase D (Roche, Basel, Swiss) and DNase I (Roche) using the GentleMACS dissociator (Miltenyi Biotec), according to the manufacturer's recommendation. Subsequently, the cells were separated using 40%/70% Percoll (GE Healthcare Life Sciences, Chicago, IL, USA) gradient and leukocytes were obtained from the interphase.
+ Open protocol
+ Expand
9

CD11b+ Cells Isolation and scRNA-seq

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD11b+ cells were obtained by immunomagnetic cell sorting using anti-CD11b microbeads (Miltenyi Biotec), following manufacturer’s instruction, or by immunopanning. Single-cell RNA sequencing and data processing were performed as previously described [10 (link)].
+ Open protocol
+ Expand
10

Isolation of Hippocampal CD11b+ and CD11b- Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hippocampus was dissected and stored in 1 mL cold HBSS buffer (hippocampus from 5 mice for Sham and Surgery group, respectively). The hippocampus was minced and dissociated in 8 mL of a mixture containing collagenase IV (5 mg/ml), DNase I (5 mg/ml) and 5% FBS, followed by bathing in water at 37 °C for 30 min. Cell suspension was then filtered through 70 µm cell strainer (BD Falcon, USA). Myelin debris was removed by using Myelin Removal Beads II (Miltenyi Biotec, Germany). Cell suspension was centrifuged at 300 g/min for 10 min then resuspended in 0.5% BSA. After incubating with anti-CD11b microbeads (Miltenyi Biotec, Germany) on ice for 15 min, CD11b+ and CD11b cells were isolated by MiniMACS separator (Miltenyi Biotec, Germany) according to the manufacturer’s instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!